Company News
Mukka Proteins Reports No Preferential Issue Fund Deviation
Mukka Proteins filed a SEBI-mandated statement confirming no deviation in utilization of ₹47 crore funds raised via preferential warrants.
The company utilized ₹11.75 crore for working capital while b
